Maze Therapeutics, Inc. (MAZE)
Across 7 earnings reports since Mar 31, 2025, Maze Therapeutics, Inc. (MAZE) has a clear post-earnings pattern. It moves ±7.32% on average after reporting and finishes higher 42.9% of the time. Its largest post-earnings gain was +4.66% (May 12, 2026) and its largest decline was -35.24% (Mar 25, 2026). The next earnings report is predicted for 2026-11-16 (estimated).
Earnings reactions
How MAZE moved on each past earnings report.
Earnings Impact
Total Earnings
7
Avg Abs. Movement
±7.32%
Positive %
42.9%
Negative %
57.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 11, 2026 | ☽ POST | +1.16% | open_in_new |
| May 12, 2026 | ☽ POST | +4.66% | open_in_new |
| Mar 25, 2026 | ☀ PRE | -35.24% | open_in_new |
| Nov 06, 2025 | ☽ POST | -3.48% | open_in_new |
Earnings Count
7
Total earnings in dataset
Avg Abs. Movement
±7.32%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260908 | open_in_new SEC.gov |
| 144 | 20260904 | open_in_new SEC.gov |
| 4 | 20260904 | open_in_new SEC.gov |
| 4 | 20260904 | open_in_new SEC.gov |
| 4 | 20260904 | open_in_new SEC.gov |
| 4 | 20260904 | open_in_new SEC.gov |
| 4 | 20260903 | open_in_new SEC.gov |
| 4 | 20260903 | open_in_new SEC.gov |
| 4 | 20260903 | open_in_new SEC.gov |
| 4 | 20260903 | open_in_new SEC.gov |
Frequently asked about MAZE earnings
When does Maze Therapeutics, Inc. report earnings next? expand_more
Maze Therapeutics, Inc. (MAZE)'s next earnings date is estimated for 2026-11-16. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does MAZE stock move after earnings? expand_more
Over 7 reports, MAZE has moved an average of ±7.32% the session after earnings, closing higher 42.9% of the time.
What was MAZE's biggest post-earnings move? expand_more
MAZE's largest post-earnings gain on record was +4.66% on May 12, 2026, and its largest decline was -35.24% on Mar 25, 2026.
Where can I find Maze Therapeutics, Inc.'s SEC filings? expand_more
All of Maze Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right